U.S. Software Stock News

Intapp (NasdaqGS:INTA) has launched Celeste, a purpose-built agentic AI platform focused on regulated professional services. The company also announced new partnerships with Anthropic to integrate Claude and with Harvey to embed Intapp Walls for ethical compliance in enterprise AI deployments. These moves aim to address compliance-heavy workflows and data governance needs for firms in legal, accounting, and investment banking. For investors watching enterprise software, Intapp sits at the...

RAPT Therapeutics (RAPT) has drawn fresh attention after a sharp move in its share performance over the past 3 months. This has prompted investors to reassess the clinical stage biotech’s risk and reward profile. See our latest analysis for RAPT Therapeutics. At a share price of US$57.96, RAPT Therapeutics has shifted sharply over the past year, with a very large 1 year total shareholder return and a long term total shareholder return that remains negative. This suggests that recent momentum...

Ryerson Holding, now trading as NYSE:RYZ, has completed its merger with Olympic Steel. The combined company has introduced substantial changes to its executive leadership team and Board of Directors. The merger includes a stock ticker change and material amendments to Ryerson Holding's credit agreement. For you as an investor, this represents a meaningful reset for a metals service center business that now blends Ryerson Holding and Olympic Steel under the NYSE:RYZ ticker. Both companies...

Innoviva (INVA) has wrapped up FY 2025 with Q4 revenue of US$114.6 million and basic EPS of US$2.19, capping a trailing 12 month period where revenue was US$411.3 million and basic EPS reached US$4.02 alongside a reported net profit margin of 65.9% that was lifted by a US$161.6 million one off gain. Over the past few quarters, the company has seen revenue move from US$88.6 million in Q1 2025 to US$114.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.74 in Q1 2025 to US$2.19...

Nomad Foods (NYSE:NOMD) closed FY 2025 with fourth quarter revenue of €773.1 million and a basic EPS loss of €0.07, capping a trailing twelve month revenue line of about €3.0 billion and EPS of €0.91 as margins compressed from a 7.3% net profit margin to 4.5% over the year. Over recent quarters, the company has seen quarterly revenue move from €793.4 million in Q4 2024 to €760.1 million in Q1 2025, €746.9 million in Q2 2025, €752.4 million in Q3 2025 and €773.1 million in Q4 2025. Basic EPS...

Intro TG Therapeutics (TGTX) just closed out FY 2025 with Q4 revenue of US$192.6 million and basic EPS of US$0.16, alongside trailing twelve month revenue of US$616.3 million and EPS of US$3.10. Over the past couple of years, the company has reported revenue increasing from US$83.9 million in Q3 2024 to US$192.6 million in Q4 2025. Quarterly basic EPS has ranged from US$0.03 in Q1 2025 to US$2.69 in Q3 2025 and US$0.16 in the latest quarter, framing this release as a check-in on how durable...

If you are wondering whether Cardinal Infrastructure Group is priced attractively today, you are not alone. The stock has been on many investors' watchlists as questions around its fair value grow louder. The share price sits at US$33.05, with returns of 2.5% over the last 7 days, 19.2% over the past 30 days, and 46.1% year to date. This has sharpened interest in what is actually built into the current valuation. Recent coverage has focused on Cardinal Infrastructure Group's role in the...

Array Technologies (ARRY) has just wrapped up FY 2025 with Q4 revenue of US$226.0 million and a basic EPS loss of US$1.06, alongside trailing twelve month revenue of about US$1.3 billion and a TTM basic EPS loss of US$0.73. The company has seen quarterly revenue range from US$231.4 million in Q3 2024 to US$393.5 million in Q3 2025, while basic EPS has swung between a loss of US$1.02 in Q3 2024 and a profit of US$0.19 in Q2 2025. This sets up a story where investors are watching how...

Fastenal (NasdaqGS:FAST) reported a 59% year over year increase in CEO Daniel L. Florness's compensation in a new SEC filing. Multiple insiders have purchased Fastenal stock over the past six months. The company has been awarded nearly $8 million in government contracts over the last year. Fastenal, trading at around $45.68 per share, has seen its stock return 13.0% year to date and 25.9% over the past year, with longer term gains of 85.9% over three years and 133.3% over five years. In...

Intellia Therapeutics (NTLA) closed FY 2025 with Q4 revenue of US$23.0 million and a basic EPS loss of US$0.83, as the company continued to invest heavily in its gene editing pipeline. Over the last six quarters, revenue has moved from US$9.1 million in Q3 2024 to US$23.0 million in Q4 2025, while quarterly basic EPS losses have ranged between US$0.83 and US$1.34. This has left margins firmly in loss-making territory even as the top line scaled up. See our full analysis for Intellia...

If you are wondering whether Farmers & Merchants Bank of Long Beach is priced attractively at around US$8,435 per share, you are not alone. This article is built to help you frame that question clearly. The stock has been relatively steady in the short term, with a 0.2% 7 day decline and returns of 1.0% over 30 days, 1.9% year to date and 50.9% over the last year, plus 29.0% over 3 years and 24.3% over 5 years. Recent coverage of Farmers & Merchants Bank of Long Beach has focused on its...

If you are wondering whether Stryker's share price around US$386 still offers value, you are not alone; many investors are trying to work out what a fair price looks like today. Over shorter periods, the stock has seen returns of 3.6% over the last 7 days, 8.9% over the last 30 days and 10.9% year to date, while the 1 year return sits at 0.2% and the 3 and 5 year returns are 51.6% and 72.4% respectively. Recent news coverage around Stryker has mainly centered on its position as a large...

Synopsys (SNPS) has kicked off Q1 2026 with total revenue of US$2.4b and basic EPS of US$0.34, setting the stage against a trailing twelve month picture that includes US$8.0b in revenue and basic EPS of US$6.40. Over recent quarters, the company has reported revenue of US$1.46b in Q1 2025, US$1.60b in Q2, US$1.74b in Q3 and US$2.25b in Q4, while quarterly basic EPS over that period ranged from US$1.91 to US$2.42. With trailing net profit margins now at 13.8% and influenced by a large one off...

WisdomTree (NYSE:WT) received SEC approval to offer intraday trading and instant settlement for tokenized shares of its Treasury Money Market Digital Fund. The approval allows 24/7 trading of these tokenized money market fund shares in the U.S. This marks a first of its kind use of blockchain infrastructure for a registered U.S. mutual fund with continuous trading and immediate settlement. WisdomTree, known for its exchange traded products and digital asset initiatives, is moving deeper...

ACM Research FY 2025 Earnings Snapshot ACM Research (ACMR) has wrapped up FY 2025 with fourth quarter revenue of US$244.4 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$901.3 million and EPS of US$1.47. Over recent periods the company has seen quarterly revenue move from US$223.5 million and EPS of US$0.49 in Q4 2024 to a peak of US$269.2 million and EPS of US$0.56 in Q3 2025 before landing at current levels. This puts the spotlight squarely on how efficiently...

Host Hotels & Resorts (HST) has wrapped up FY 2025 with fourth quarter total revenue of US$1.6 billion and basic EPS of US$0.20, alongside funds from operations of US$340 million that remain the key gauge for this REIT. Over recent quarters, the company has seen revenue move from US$1.42 billion in Q4 2024 to US$1.60 billion in Q4 2025, while basic EPS shifted from US$0.15 to US$0.20. This gives investors a clearer view of how the top line and per share results are tracking into the latest...

If you are looking at Bausch Health Companies and wondering whether the current share price reflects its underlying value, you are not alone. The stock last closed at US$6.04, with returns of 1.9% over the past week and 5.6% over the past month, against year to date and 1 year returns of 16.2% and 21.0% declines, and a 34.7% and 81.1% decline over 3 and 5 years respectively. These moves have kept valuation in focus for many investors, especially as headlines continue to frame Bausch Health...

Teleflex (TFX) has just posted its FY 2025 fourth quarter numbers, with revenue of US$569 million and a basic EPS loss of US$0.08, while trailing twelve month revenue sits at US$2.0 billion and EPS at US$1.31. Over recent quarters, revenue has ranged from US$569 million to US$913 million, with quarterly basic EPS swinging between a loss of US$9.24 and a profit of US$2.77. This underscores how headline earnings have been heavily affected by discontinued operations and one off items. With...

Payoneer Global FY 2025 Earnings Snapshot Payoneer Global (PAYO) has capped FY 2025 with fourth quarter total revenue of US$274.7 million and basic EPS of US$0.05, while trailing twelve month revenue sits at about US$1.1 billion alongside basic EPS of roughly US$0.20. Over recent periods, the company has seen quarterly revenue move from US$261.7 million in Q4 2024 to US$274.7 million in Q4 2025, with basic EPS shifting between US$0.05 and US$0.06 over the FY 2025 quarters. With trailing net...

IonQ (IONQ) has just wrapped up FY 2025 with fourth quarter revenue of about US$61.9 million and basic EPS of US$2.18, alongside trailing 12 month revenue of roughly US$130.0 million and basic EPS of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue range from US$7.6 million in early 2025 to US$39.9 million in the third quarter and then to US$61.9 million in the fourth quarter, while basic EPS has moved from a loss of US$0.93 in late 2024 to a loss of...

Lantheus Holdings (LNTH) has just closed out FY 2025 with Q4 revenue of US$406.8 million and basic EPS of US$0.82, alongside trailing twelve month revenue of about US$1.5 billion and basic EPS of US$3.46 that frame the latest quarter in a broader earnings context. Over the past few quarters, the company has seen revenue move from US$372.8 million in Q1 2025 to US$406.8 million in Q4 2025, while quarterly basic EPS shifted from US$1.06 to US$0.82 and trailing net profit margin sits at 15.2%...

Protagonist Therapeutics (PTGX) closed FY 2025 with Q4 revenue of US$7.4 million and a basic EPS loss of US$0.69, alongside a Q4 net loss of US$44.4 million. On a trailing twelve month basis, revenue was US$46.0 million with a basic EPS loss of US$2.05 and a net loss of US$130.1 million. The company has reported quarterly revenue ranging from US$28.3 million in Q1 2025 down to US$4.7 million in Q3 2025. Basic EPS moved from a loss of US$0.19 in Q1 to a loss of US$0.62 in Q3 before reaching a...

In February 2026, Camping World Holdings reported fourth-quarter and full-year 2025 results showing quarterly revenue of US$1,173.56 million and a widening net loss of US$67.3 million, alongside a full-year net loss of US$89.8 million despite higher annual revenue of US$6,369.15 million. At the same time, the board paused Camping World’s regular quarterly cash dividend to prioritize reducing net debt leverage amid tax law changes and weaker profitability, marking a significant shift in how...

Joby Aviation (JOBY) has just wrapped up FY 2025 with Q4 revenue of US$30.8 million and a basic EPS loss of US$0.14, alongside trailing twelve month revenue of US$53.4 million and a TTM basic EPS loss of US$1.13. Over recent quarters, the company has moved from effectively zero revenue in early 2025 to US$22.6 million in Q3 and US$30.8 million in Q4. Quarterly basic EPS losses ranged between US$0.11 and US$0.48. This sets up a story where top line traction is building against a backdrop of...